UPL announced that its wholly owned subsidiary, UPL Corporation (formerly Biowin Corporation) has successfully completed the pricing of its USD 300 million senior unsecured notes ('Notes') at 4.5 % per annum, due 2028.

The Notes have been rated 'BBB-' by Fitch, and 'BBB-' by S&P. An application is filed to the Singapore Stock Exchange for the listing of the Notes. The offering is scheduled to close on 08 March 2018.

Shares of the company declined Rs 9.2, or 1.29%, to trade at  Rs 705.40.  The total volume of shares traded  was  54,934 at the BSE (12.59 p.m., Monday).